Beetham Thomas W.

Viridian Therapeutics, Inc.\de

Chief Operating Officer

Avg. Two Year Performance

No Purchase Track Record
No Sale Track Record

Holdings: 6.0K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

$117.05K Net Amount
Buy:$117.05K$23.41
Sell:0--

Sentiment

Insider Trading Sentiment: Strong Buy

Company Sentiment

Medical Laboratories & Research

Health Services

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions